Friday, July 12, 2024
wellness India Expo
Home Tags Sun Pharma

Tag: Sun Pharma

Sun Pharma plans to acquire stake in HaystackAnalytics

HaystackAnalytics is engaged in the business of developing genomic analysis software

Sun Pharma to present results of the Phase III PIVOTAL trial...

PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy

Taro’s merger with Sun Pharma gets approval from its shareholders

Combined entity to enhance global healthcare services, expected to finalize in 35 days

Sun Pharma chairman, Israel Makov to retire on completion of term

Leading the company’s global expansion, he guided the acquisition of Ranbaxy in 2014, making Sun Pharma the leader in the Indian pharmaceutical market and a strong player globally

Dr. Bushra Ateeq wins Sun Pharma Science Foundation Research Award-2021

An IIT Kanpur professor, Dr. Ateeq’s research interest involves exploration of the genetic and epigenetic changes that initiate cancer and its progression

Sun Pharma to set up an end to end manufacturing facility...

The opening of this facility will lead to the creation of more jobs and will contribute to the enhancement of the industrial sector in the state.

Sun Pharma Advanced Research signs licensing deal with Biomodifying LLC

SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target

National Doctors’ Day: Sun Pharma’s ‘Sunkalp’ initiative for doctors & their...

As a special tribute, announces various initiatives for the welfare of doctors, their families and the community....................

Sun Pharma to market Ferring Pharmaceuticals’s obstetric drug ‘CARITEC’ in India

As per the company, CARITEC is an innovative obstetric drug for preventing post-partum hemorrhage. It is a Room Temperature Stable (RTS) formulation of Carbetocin and addresses limitations in refrigeration and cold-chain transportation.......................

DigiHealth to invest in developing a world-class supply chain & distribution...

The investment has been made with a view to develop a world-class pharmaceutical supply chain & distribution IT ecosystem and support the government’s National Digital Health Mission.............................